.svg)
India’s food regulator has launched legal proceedings against Nestle after finding a baby formula sample failed to meet prescribed biotin standards.
Mariyam Adheela
A view of the logo during the Annual General Meeting of Nestle in Ecublens near Lausanne, Switzerland --Photo: REUTERS/Denis Balibouse
New Delhi: India’s food safety regulator has initiated legal action against Nestle after a sample of its infant follow up formula was found to contain biotin levels that did not meet the country’s prescribed standards.
The Food Safety and Standards Authority of India (FSSAI) said a sample of Nestle’s follow up formula was found to be substandard for biotin, also known as vitamin B7.
The regulator said a reanalysis by a referral laboratory confirmed that the sample did not comply with the biotin requirements under Indian regulations.
FSSAI also filed two separate cases against Nestle over alleged misleading claims on NAN Excella Pro Stage 1 and Lactogen Pro 1 baby food products.
Nestle India said its products are fully compliant with applicable regulations and that it would continue cooperating with the regulator.
The company also said statements on the labels under scrutiny were factual and supported by scientific literature, adding that the labels had previously been approved by an FSSAI expert committee.
FSSAI has not indicated whether the affected formula will be recalled. The action comes as Indian authorities increase food safety inspections and testing across the country’s large food industry.
